Jing Qu1, Huaping Chen1, Lanyan Zhu2, Namasivayam Ambalavanan3, Christopher A Girkin4, Joanne E Murphy-Ullrich5, J Crawford Downs6, Yong Zhou7. 1. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States. 2. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States 2The Second Xiangya Hospital, Central-South University, Changsha, Hunan, China. 3. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States. 4. Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama, United States. 5. Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama, United States 5Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States. 6. Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama, United States 6Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, Alabama, United States. 7. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States 4Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, Alabama, United States 6Department of Biomedical Engineering, University of Alab.
Abstract
PURPOSE: To determine the effects of altered mechanical strain on human peripapillary scleral (ppSc) fibroblast-to-myofibroblast differentiation. METHODS: Eight human ppSc fibroblast cultures were isolated from three paired eyes and two unilateral eyes of five donors using an explant approach. Human ppSc fibroblast isolates were subjected to 1% and 4% cyclic strain at 0.05 to 5 Hz for 24 hours. Levels of α smooth muscle actin (αSMA) mRNA and protein were determined by real-time PCR and immunoblot. Incorporation of αSMA into actin stress fibers was evaluated by confocal immunofluorescent microscopy. Myofibroblast contractility was measured by fibroblast-populated three-dimensional collagen gel contraction assay and phosphorylation of myosin light chain (MLC20). RESULTS: Human ppSc fibroblasts contained 6% to 47% fully differentiated myofibroblasts before strain application; 4% cyclic strain increased αSMA mRNA and protein expression in ppSc fibroblasts compared with 1% strain applied at 5 Hz, but not at lower frequencies. Seven of eight ppSc fibroblast isolates responded to high-magnitude and high-frequency strain with increased cellular contractility and increased MLC20 phosphorylation. In addition, increasing strain frequency promoted αSMA expression in ppSc fibroblasts under both 1% and 4% strain conditions. CONCLUSIONS: High-magnitude and/or high-frequency mechanical strain promotes differentiation of human ppSc fibroblasts into contractile myofibroblasts, a fibroblast phenotypic change known to be key to tissue injury-repair responses. These findings suggest that the cellular constituent of ppSc may play an important role in the regulation of optic nerve head biomechanics in response to injurious IOP fluctuations.
PURPOSE: To determine the effects of altered mechanical strain on human peripapillary scleral (ppSc) fibroblast-to-myofibroblast differentiation. METHODS: Eight human ppSc fibroblast cultures were isolated from three paired eyes and two unilateral eyes of five donors using an explant approach. Human ppSc fibroblast isolates were subjected to 1% and 4% cyclic strain at 0.05 to 5 Hz for 24 hours. Levels of α smooth muscle actin (αSMA) mRNA and protein were determined by real-time PCR and immunoblot. Incorporation of αSMA into actin stress fibers was evaluated by confocal immunofluorescent microscopy. Myofibroblast contractility was measured by fibroblast-populated three-dimensional collagen gel contraction assay and phosphorylation of myosin light chain (MLC20). RESULTS:Human ppSc fibroblasts contained 6% to 47% fully differentiated myofibroblasts before strain application; 4% cyclic strain increased αSMA mRNA and protein expression in ppSc fibroblasts compared with 1% strain applied at 5 Hz, but not at lower frequencies. Seven of eight ppSc fibroblast isolates responded to high-magnitude and high-frequency strain with increased cellular contractility and increased MLC20 phosphorylation. In addition, increasing strain frequency promoted αSMA expression in ppSc fibroblasts under both 1% and 4% strain conditions. CONCLUSIONS: High-magnitude and/or high-frequency mechanical strain promotes differentiation of human ppSc fibroblasts into contractile myofibroblasts, a fibroblast phenotypic change known to be key to tissue injury-repair responses. These findings suggest that the cellular constituent of ppSc may play an important role in the regulation of optic nerve head biomechanics in response to injurious IOP fluctuations.
Authors: James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown Journal: Nat Rev Mol Cell Biol Date: 2002-05 Impact factor: 94.444
Authors: Claude F Burgoyne; J Crawford Downs; Anthony J Bellezza; J-K Francis Suh; Richard T Hart Journal: Prog Retin Eye Res Date: 2005-01 Impact factor: 21.198
Authors: J C Downs; M E Ensor; A J Bellezza; H W Thompson; R T Hart; C F Burgoyne Journal: Invest Ophthalmol Vis Sci Date: 2001-12 Impact factor: 4.799
Authors: Jihee Kim; Stuart K Gardiner; Andrea Ramazzotti; Udayakumar Karuppanan; Luigi Bruno; Christopher A Girkin; J Crawford Downs; Massimo A Fazio Journal: Exp Eye Res Date: 2021-08-08 Impact factor: 3.770
Authors: Sarah Baldivia; Alexander Levy; Shylaja Hegde; Stijn J A Aper; Maarten Merkx; Rafael Grytz Journal: PLoS One Date: 2016-11-21 Impact factor: 3.240
Authors: Ian Pitha; Ericka Oglesby; Amanda Chow; Elizabeth Kimball; Mary Ellen Pease; Julie Schaub; Harry Quigley Journal: Transl Vis Sci Technol Date: 2018-11-14 Impact factor: 3.283
Authors: Daniel C Turner; Anna M Edmiston; Ye Emma Zohner; Kevin J Byrne; William P Seigfreid; Christopher A Girkin; Jeffrey S Morris; J Crawford Downs Journal: Invest Ophthalmol Vis Sci Date: 2019-06-03 Impact factor: 4.799
Authors: Jessica V Jasien; Brian C Samuels; James M Johnston; J Crawford Downs Journal: Invest Ophthalmol Vis Sci Date: 2020-02-07 Impact factor: 4.799